Double masked evaluation of Acular LS [ketorolac] versus Nevanac [nepafenac] for postoperative pain control in eyes undergoing PRK [photorefractive keratotomy]

Next Previous
Trial Profile

Double masked evaluation of Acular LS [ketorolac] versus Nevanac [nepafenac] for postoperative pain control in eyes undergoing PRK [photorefractive keratotomy]

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Mar 2009

At a glance

  • Drugs Ketorolac; Nepafenac
  • Indications Postoperative pain
  • Focus Therapeutic Use

    • Most Recent Events

    • 06 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top